United Therapeutics (UTHR) Tops Q1 EPS by 7c, Miss on Revenues
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $508.22 +1.70%
Financial Fact:
Net product sales: 408.2M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Net product sales: 408.2M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $3.61, $0.07 better than the analyst estimate of $3.54. Revenue for the quarter came in at $370.5 million versus the consensus estimate of $398.18 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
- Is Treasury selloff a major issue for stock market bulls?
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
